tiprankstipranks
Trending News
More News >
Biofrontera AG (DE:B8FK)
XETRA:B8FK
Germany Market

Biofrontera (B8FK) Financial Statements

Compare
3 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently €14.71M. The company's EPS TTM is €; its P/E ratio is -6.96; Biofrontera is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 32.25M€ 25.74M€ 28.79M€ 30.35M€ 31.27M
Gross Profit€ 25.37M€ 20.98M€ 24.87M€ 26.81M€ 26.39M
Operating Income€ 4.78M€ 1.59M€ -15.88M€ -5.61M€ -2.07M
EBITDA€ 5.57M€ 2.34M€ -12.59M€ -277.00K€ -20.22M
Net Income€ -369.00K€ -44.17M€ 37.75M€ -13.02M€ -7.36M
Balance Sheet
Cash & Short-Term Investments€ 3.08M€ 6.38M€ 6.91M€ 16.56M€ 12.20M
Total Assets€ 30.73M€ 32.73M€ 76.13M€ 56.39M€ 58.36M
Total Debt€ 1.15M€ 1.50M€ 3.30M€ 23.88M€ 23.32M
Net Debt€ -1.93M€ -4.88M€ -3.61M€ 7.33M€ 12.20M
Total Liabilities€ 10.75M€ 12.39M€ 18.70M€ 49.02M€ 48.41M
Stockholders' Equity€ 19.98M€ 20.34M€ 57.43M€ 7.38M€ 9.96M
Cash Flow
Free Cash Flow€ -2.83M€ -4.88M€ 29.81M€ -3.62M€ -34.75M
Operating Cash Flow€ -1.92M€ -3.90M€ 30.44M€ -2.85M€ -32.89M
Investing Cash Flow€ -912.00K€ -981.00K€ -42.26M€ 2.87M€ 21.05M
Financing Cash Flow€ -467.00K€ 4.34M€ 2.18M€ 5.95M€ 3.46M
Currency in EUR

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.